Related Party Disclosures (Tables)

12 Months Ended

Dec. 31, 2024

Our key management personnel have been defined as the members of the Management Board and the

Supervisory Board. Key management personnel compensation is comprised of the following:



	Years ended December 31,

(in millions €)	2024	2023	2022
Management Board(1)	13.0	8.3	15.0
Fixed compensation	4.0	3.9	2.9
Fringe benefits	0.2	—	—
Short-term incentive – first installment	0.8	0.7	0.6
Short-term incentive – second installment(2)	0.6	1.0	0.7
Other variable compensation(3)	1.3	0.8	0.1
Share-based payments (incl. long-term incentive)(4)	6.1	1.9	10.7
Supervisory Board	0.9	0.6	0.5
Total compensation of key management personnel	13.9	8.9	15.5

(1)During the year ended December 31, 2024, Sean Marett retired from the Management Board with effect as of July 1,

2024. Therefore, his compensation until his departure date is presented on a pro-rata basis in this table. The following

compensation pursuant to his separation agreement subsequent to his departure date and thus as former Management

Board member are not included in this table: a severance payment of €275,000, an additional payment of €39,000 in

respect of the 2024 STI, a grant of 5,760 phantom options in respect of the 2024 LTI and a payment of €477,030 in

relation to his 12-months consultancy agreement.

(2)The fair value of the second installment of the short-term incentive compensation which has been classified as a cash-

settled share-based payment arrangement was determined pursuant to the regulations of IFRS 2 “Share-based

Payments”. This table shows the pro-rata share of personnel expenses for the respective financial year, which are

recognized over the award’s vesting period beginning as of the service commencement date (date when entering or

renewing service agreements) until each separate determination date and are remeasured until settlement date.

(3)Represents for the financial year 2024 the cash payment related to the one-time signing bonus granted to Annemarie

Hanekamp as part of her appointment to the Management Board, designed to compensate her for lower bonus payments

that she would receive as part of her compensation package with BioNTech and to recognize and appreciate her move to

BioNTech. For 2023, the amount represents the one-time signing cash payment related to James Ryan’s appointment to

the Management Board to provided compensation in lieu of participation in the LTI 2023 program and the one-time

special cash payment related to Jens Holstein to honor his contribution to BioNTech’s extraordinary financial

performance. For 2022, the amount includes a one-time signing and retention cash payment agreed when renewing the

service agreement agreed with Sean Marett in 2022.

(4)The fair value of the share-based payments was determined pursuant to the regulations of IFRS 2 “Stock-based

Payments”. This table shows the pro-rata share of personnel expenses resulting from stock-based compensation for the

respective financial year. During the years ended December 31, 2024, 2023 and 2022, the amounts included expenses

derived from a one-time signing bonus granted to Jens Holstein as of his appointment to the Management Board in the

form of 4,246 phantom shares as well as expenses derived from the one-time signing bonus granted to Annemarie

Hanekamp as of her appointment to the Management Board in the form of shares in the amount of €500,000.

The total amount of transactions with ATHOS KG or entities controlled by it was as follows for the periods

indicated:



	Years ended December 31,

(in millions €)	2024	2023	2022
Purchases of various goods and services from entities controlled by ATHOS KG	0.2	0.3	0.3
Purchases of property and other assets from entities controlled by ATHOS KG	—	—	62.5
Total	0.2	0.3	62.8

The outstanding balances of transactions with ATHOS KG or entities controlled by them were as follows as of the